
June 26 (Reuters) - Novo Nordisk A/S NOVOb.CO:
NOVO NORDISK CONTINUES EFFORTS TO SUPPORT PATIENT ACCESS TO AUTHENTIC, FDA APPROVED WEGOVY® AND PRIORITIZE PATIENT SAFETY
NOVO NORDISK A/S - NEW $299 SAVINGS OFFER FOR WEGOVY STARTING JULY 1
NOVO NORDISK A/S - COLLABORATES WITH WEIGHTWATCHERS FOR WEGOVY ACCESS
Further company coverage: [NOVOb.CO]